Net profit of Novo Nordisk according to IFRS for 9 months of 2020 amounted to kr.32.82 billion, having increased by 8.6% compared to kr.30.234 billion in the previous year. Revenue increased by 5.8% to kr.94.808 billion compared to kr.89.604 billion a year earlier.